Dr. Duffield on Implications for Immunotherapy in Nasopharyngeal CarcinomaByAmy Duffield, MD, PhDApril 20th 2018Amy Duffield, MD, PhD, assistant professor of pathology, Johns Hopkins University School of Medicine, member, Johns Hopkins Kimmel Cancer Center, discusses the implications for immunotherapy in nasopharyngeal carcinoma.